Neurology Clinic III – Neurophysiological Clinic – Multiple Sclerosis Treatment Center

Appointments: by phone: 037/ 6545 456,

in writing at the address: Multiple Sclerosis Treatment Center, Neurology Clinic of the Nitra University Hospital, Špitálska 6, 950 01 Nitra,

or by email: dominika.raticova@fnnitra.sk

For the first examination, the patient needs a referral from their general practitioner or a neurologist. The patient must bring the results of any examinations already performed, in particular MRI scans (Magnetic Resonance Imaging – recorded on a CD), cerebrospinal fluid test results, hospital discharge reports, and complete medical documentation. The Center (outpatient clinic) for the Treatment of Multiple Sclerosis (MS) is engaged in the diagnosis, treatment, consultative, and supraregional care of patients with demyelinating diseases of the central nervous system (CNS), predominantly MS. Its aim is to provide early diagnosis and treatment of demyelinating diseases starting from the stage of the first clinical symptoms. The Center currently monitors around 1,000 patients with this serious disease. Treatment at the Center includes the most advanced immunomodulatory and immunosuppressive therapies, administered in accordance with the applicable indication criteria for such treatment. The outpatient clinic makes use of the diagnostic and therapeutic facilities of the Neurology Clinic – the electrophysiology unit (evoked potentials, electromyography, botulinum toxin treatment for spasticity), as well as the neuropsychology, speech therapy, and immunology outpatient clinics. Since this disease requires a multidisciplinary approach due to the diversity of its symptoms, we also cooperate within the Nitra University Hospital with other specialized outpatient clinics and departments (urology, gynecology, pulmonology, rehabilitation, ophthalmology). In cooperation with the Jessenius s.r.o. radiodiagnostic facility, we provide state-of-the-art MRI examinations, including advanced specific sequences, particularly for the differential diagnosis of other white matter diseases of the brain. The Center is also involved in several international clinical trials monitoring the efficacy and safety of new treatment medications.